Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
10 February 2023
Closing Date:
08 March 2023
Location(s):
PL416 Kaliski (PL Poland/POLSKA)
Description:
Successive supplies of pharmaceutical products — oncological drugs

Successive deliveries of pharmaceutical products – oncological drugs. Contractors who meet the conditions for participation in the procedure may apply for the award of the contract – i.e. they have a concession, permit or license for wholesale trade in medicinal products; The subject of the contract consists of 15 indivisible tasks, the detailed description of which, due to the limited number of characters, can be found in the Terms of Contract Specification

Trastuzumab intravenous

Trastuzumab intravenous

aflibercept

aflibercept

Palbociclib

Palbociclib

Doxorubicin liposomal

Doxorubicin liposomal

Nivolumab

Nivolumab

CABOZANTINIB

CABOZANTINIB

Pegfilgrastim

Pegfilgrastim

Trastuzumab emtansine

Trastuzumab emtansine

Subcutaneous Trastuzumab

Subcutaneous Trastuzumab

Pertuzumab

Pertuzumab

Lapatinib

Lapatinib

panitumumab

panitumumab

Trifluridine/Tripiracil

Trifluridine/Tripiracil

Abemaciclib

Abemaciclib

Ribociclib

Ribociclib

Download full details as .pdf
The Buyer:
Wojewódzki Szpital Zespolony im. Ludwika Perzyny w Kaliszu
CPV Code(s):
33600000 - Pharmaceutical products